Derdák et al. [47], using a UCP2 knockout mouse model, provided the first in vivo evidence for a link between UCP2 and cancer, when transgenic mice showed an imbalance between epithelial cell proliferation and apoptosis. This evidence concerns the gene UCP2 and cancer.